Filing Flows

Filing Flows › Companies › ReposiTrak › Cash flow

ReposiTrak cash flow, quarter by quarter

Latest: Q4 FY26 · from the cash-flow statements filed with the SEC

Free cash flow$2.4M in Q4 FY26

Operating cash flow$2.4M
Capital spending−$5K
Free cash flow+$2.4M
Cash / net income1.1×
Cash conversion cycle34 days

Analysis

In Q4 FY26, ReposiTrak generated $2.4M of operating cash flow and spent $5K on capital projects, leaving free cash flow of $2.4M. That is $710K more than in Q4 FY25 ($1.6M).

Operating cash flow was $2.4M against net income of $2.1M — 1.1× profit, cash ran ahead of reported earnings. The largest differences: prepaid and other assets +$873K, deferred revenue +$755K, accrued liabilities +$717K.

Its cash conversion cycle was 34 days (receivables 79 + inventory 0 − payables 45).

Free cash flow

ReposiTrak: free cash flow by quarterReposiTrak: free cash flow by quarter$1.9MQ1 FY25$3.5MQ2 FY25$1.4MQ3 FY25$1.6MQ4 FY25$1.5MQ1 FY26$2.2MQ2 FY26$2.1MQ3 FY26$2.4MQ4 FY26
Operating cash flow less capital spending.
ReposiTrak: operating cash flow against capital spendingReposiTrak: operating cash flow against capital spendingOperating cash flowCapital spending$1.9M$0Q1 FY25$3.5M$0Q2 FY25$1.4M$9KQ3 FY25$1.7M$7KQ4 FY25$1.5M$12KQ1 FY26$2.2M−$1Q2 FY26$2.1M$0Q3 FY26$2.4M$5KQ4 FY26
Latest (Q4 FY26): Operating cash flow $2.4M, Capital spending $5K.

Capital allocation, year by year

ReposiTrak: where the cash came from (up) and went (down), by fiscal yearReposiTrak: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingBuybacksDividendsFY22: Operating cash flow $6.1MFY22: Net borrowing −$3.4MFY22: Shares issued $109KFY22: Asset sales $1.4MFY22: Capital spending −$51KFY22: Buybacks −$6.1MFY22: Dividends −$586K$7.6MFY22FY23: Operating cash flow $8.9MFY23: Net borrowing −$2.8MFY23: Shares issued $93KFY23: Capital spending −$134KFY23: Buybacks −$1.3MFY23: Dividends −$1.4M$9.0MFY23FY24: Operating cash flow $7.0MFY24: Net borrowing −$207KFY24: Shares issued $112KFY24: Capital spending −$73KFY24: Buybacks −$1.5MFY24: Dividends −$1.7M$7.1MFY24FY25: Operating cash flow $8.4MFY25: Net borrowing −$362KFY25: Shares issued $134KFY25: Capital spending −$16KFY25: Buybacks −$200KFY25: Dividends −$1.7M$8.6MFY25FY26: Operating cash flow $8.2MFY26: Net borrowing −$216KFY26: Shares issued $105KFY26: Capital spending −$17KFY26: Buybacks −$1.8MFY26: Dividends −$1.6M$8.3MFY26
Over these 5 years operating cash flow totalled $38.6M; the largest uses were buybacks ($11.0M) and dividends ($7.0M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$27.3M
Debt$294K
Net cash$27.0M
Due within a year$233K

ReposiTrak funds itself: free cash flow was — over the last twelve months, and $27.3M of cash and investments stands against $294K of debt ($233K due within a year, 117.1× covered by cash).

Where the cash came from and went

ReposiTrak: sources (+) and uses (−) of cash, Q4 FY26ReposiTrak: sources (+) and uses (−) of cash, Q4 FY26Operating cash flow$2.4MOther investing−$1.1MCash drawn (+) / kept (−)−$846KDividends−$398KNet borrowing (+) / repaid (−)−$55KCapital spending−$5K

From profit to cash

ReposiTrak: net income to operating cash flow, Q4 FY26ReposiTrak: net income to operating cash flow, Q4 FY26Net income$2.1MDepreciation & amortization$85KStock-based pay$117KReceivables−$75KPayables$252KAccrued liabilities$717KDeferred revenue$755KPrepaid and other assets$873KOperating cash flow$2.4M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q4 FY2679—4534
Q3 FY2676—2650
Q2 FY2672—2745
Q1 FY2665—3233
Q4 FY2561—2933
Q3 FY2553—2925
Q2 FY2556—2927
Q1 FY2559—3227

Every quarter

QuarterOperating cash flowCapital spendingBuybacksDividendsNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q4 FY26$2.4M−$5K—−$398K−$55K—−$846K$2.4M
Q3 FY26$2.1M—−$550K−$411K−$54K$41K$2.3M$2.1M
Q2 FY26$2.2M$1−$1.1M−$424K−$53K—$88K$2.2M
Q1 FY26$1.5M−$12K−$150K−$403K−$53K$63K−$226K$1.5M
Q4 FY25$1.7M−$7K−$100K−$314K−$52K$1−$434K$1.6M
Q3 FY25$1.4M−$9K—−$510K−$139K$70K−$93K$1.4M
Q2 FY25$3.5M—−$100K−$409K−$18K$4K−$2.3M$3.5M
Q1 FY25$1.9M——−$423K−$154K$60K−$636K$1.9M

ReposiTrak: income statement and cash flow

ReposiTrak, Q4 FY26: revenue $5.6M (-3% year over year), operating margin 33.7%. The chart follows the revenue to costs, profit and cash.

ReposiTrak: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.